{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:09:05Z","timestamp":1779149345343,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Amrita Vishwa Vidyapeetham, Coimbatore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44969-5","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:44:29Z","timestamp":1775065469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of P2Y12 G52T genetic polymorphism with recurrent thromboembolic events in stroke and myocardial infarction patients on clopidogrel therapy: a prospective observational study"],"prefix":"10.1038","volume":"16","author":[{"given":"Anite","family":"Baiju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Riyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rajalakshmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chameli","family":"Ratan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjana","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariya","family":"Rapheal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. T. Karthika","family":"Rani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish Kumar","family":"Jeengar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divyasree","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarath","family":"Sreekumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. R.","family":"Roshni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafiul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish P.","family":"Thunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rajalakshmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaladhar","family":"kamalasanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Uday","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"44969_CR1","doi-asserted-by":"crossref","unstructured":"Kambhampati, N. T. et al. Cytochrome P450 2C19 polymorphisms and its association with major adverse cardiac events in post-coronary intervention patients on clopidogrel in the tertiary care center. Cureus [Internet]. 2023 [cited 2025 May 28];15(2):e34737. Available from: https:\/\/www.cureus.com\/articles\/133507-cytochrome-p450-2c19-polymorphisms-and-its-association-with-major-adverse-cardiac-events-in-post-coronary-intervention-patients-on-clopidogrel-in-the-tertiary-care-center","DOI":"10.7759\/cureus.34737"},{"issue":"7","key":"44969_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26071987","volume":"26","author":"MA Akkaif","year":"2021","unstructured":"Akkaif, M. A. et al. The role of genetic polymorphism and other factors on clopidogrel resistance (CR) in an Asian population with coronary heart disease (CHD). Molecules 26(7), 1987. https:\/\/doi.org\/10.3390\/molecules26071987 (2021).","journal-title":"Molecules"},{"issue":"2","key":"44969_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40262-014-0230-6","volume":"54","author":"X-L Jiang","year":"2015","unstructured":"Jiang, X.-L., Samant, S., Lesko, L. J. & Schmidt, S. Clinical pharmacokinetics and pharmacodynamics of clopidogrel. Clin. Pharmacokinet. 54(2), 147\u201366. https:\/\/doi.org\/10.1007\/s40262-014-0230-6 (2015).","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"44969_CR4","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.4103\/jfmpc.jfmpc_1473_23","volume":"13","author":"A Pradhan","year":"2024","unstructured":"Pradhan, A., Bhandari, M., Vishwakarma, P. & Sethi, R. Clopidogrel resistance and its relevance: Current concepts. J. Family Med. Prim. Care. 13(6), 2187\u201399. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1473_23 (2024).","journal-title":"J. Family Med. Prim. Care."},{"issue":"1","key":"44969_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.62347\/IBGQ2413","volume":"18","author":"J Lv","year":"2025","unstructured":"Lv, J., Chen, A., Xu, C., Shao, G. & Zhao, M. Association of ABCB1 gene polymorphisms with aspirin or clopidogrel resistance in ischemic stroke: a meta-analysis. Int. J. Clin. Exp. Pathol. 18(1), 1\u201311. https:\/\/doi.org\/10.62347\/IBGQ2413 (2025).","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"44969_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10482-7","volume":"52","author":"S Eskandarian","year":"2025","unstructured":"Eskandarian, S., Zafarani, A., Tandel, P., Tamaddon, G. & Amini, A. Evaluation of response to clopidogrel in patients with CYP2C19*2\/*3 polymorphisms and its association with miR-19b expression. Mol. Biol. Rep. 52(1), 374. https:\/\/doi.org\/10.1007\/s11033-025-10482-7 (2025).","journal-title":"Mol. Biol. Rep."},{"issue":"19","key":"44969_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/app11199078","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. The role and molecular mechanism of P2Y12 receptors in the pathogenesis of atherosclerotic cardiovascular diseases. Appl. Sci. (Basel) 11(19), 9078. https:\/\/doi.org\/10.3390\/app11199078 (2021).","journal-title":"Appl. Sci. (Basel)"},{"issue":"3","key":"44969_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10557-022-07370-8","volume":"38","author":"D Danielak","year":"2024","unstructured":"Danielak, D., Pawlak, K., G\u0142\u00f3wka, F. & Kara\u017aniewicz-\u0141ada, M. Influence of genetic and epigenetic factors of P2Y12 receptor on the safety and efficacy of antiplatelet drugs. Cardiovasc. Drugs Ther. 38(3), 621\u201336. https:\/\/doi.org\/10.1007\/s10557-022-07370-8 (2024).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"44969_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/VHRM.S386107","volume":"19","author":"R Hidayat","year":"2023","unstructured":"Hidayat, R. et al. Correlation P2Y12 genetic polymorphism as risk factor of clopidogrel resistance in Indonesian stroke patients. Vasc. Health Risk Manag. 19, 53\u201361. https:\/\/doi.org\/10.2147\/VHRM.S386107 (2023).","journal-title":"Vasc. Health Risk Manag."},{"issue":"4","key":"44969_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/09537104.2012.693992","volume":"24","author":"R Kar","year":"2013","unstructured":"Kar, R. et al. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms. Platelets 24(4), 297\u2013302. https:\/\/doi.org\/10.3109\/09537104.2012.693992 (2013).","journal-title":"Platelets"},{"issue":"1","key":"44969_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.55627\/pmc.001.01.0107","volume":"1","author":"M Ahmed","year":"2021","unstructured":"Ahmed, M., Bangash, M. H. & Rafique, M. Polymorphism in the P2Y12 gene & antiplatelet response to clopidogrel in the Pakistani population. Precis. Med. Com. 1(1), 9\u201316. https:\/\/doi.org\/10.55627\/pmc.001.01.0107 (2021).","journal-title":"Precis. Med. Com."},{"issue":"11","key":"44969_CR12","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00228-020-02946-5","volume":"76","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Body weight, CYP2C19, and P2Y12 receptor polymorphisms relate to clopidogrel resistance in a cohort of Chinese ischemic stroke patients with aspirin intolerance. Eur. J. Clin. Pharmacol. 76(11), 1517\u20131527. https:\/\/doi.org\/10.1007\/s00228-020-02946-5 (2020).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"44969_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18134-y","volume":"8","author":"HJ Joo","year":"2018","unstructured":"Joo, H. J. et al. Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study. Sci. Rep. 8, 1229. https:\/\/doi.org\/10.1038\/s41598-017-18134-y (2018).","journal-title":"Sci. Rep."},{"issue":"23","key":"44969_CR14","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1093\/eurheartj\/ehr373","volume":"32","author":"C Patrono","year":"2011","unstructured":"Patrono, C. et al. Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J. 32(23), 2922\u20132932. https:\/\/doi.org\/10.1093\/eurheartj\/ehr373 (2011).","journal-title":"Eur Heart J."},{"issue":"1","key":"44969_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.apsb.2024.08.008","volume":"15","author":"H Li","year":"2025","unstructured":"Li, H. et al. Real-time platelet P2Y12 receptor occupancy as a promising pharmacodynamics biomarker for bridging the gap between PK\/PD of clopidogrel therapy. Acta Pharm Sin B 15(1), 484\u2013493. https:\/\/doi.org\/10.1016\/j.apsb.2024.08.008 (2025).","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"44969_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.70003","volume":"39","author":"H Ta Anh","year":"2025","unstructured":"Ta Anh, H. et al. Association of P2RY12 gene variants and non-genetic factors with clopidogrel responsiveness in Vietnamese patients after percutaneous coronary intervention: A cross-sectional study. J. Clin. Lab. Anal. 39(5), e70003. https:\/\/doi.org\/10.1002\/jcla.70003 (2025).","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"44969_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-02988-w","volume":"22","author":"YJ Zhang","year":"2022","unstructured":"Zhang, Y. J. et al. Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease. BMC Cardiovasc. Dis. 22(1), 575. https:\/\/doi.org\/10.1186\/s12872-022-02988-w (2022).","journal-title":"BMC Cardiovasc. Dis."},{"issue":"3","key":"44969_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/rth2.12213","volume":"3","author":"PP Wadowski","year":"2019","unstructured":"Wadowski, P. P. et al. Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors. Res. Pract. Thromb. Haemost. 3(3), 383\u2013390. https:\/\/doi.org\/10.1002\/rth2.12213 (2019).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"44969_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/09727531251379157","author":"B Sukumaran","year":"2025","unstructured":"Sukumaran, B. et al. Prevalence of CYP2C19 Poor Metabolisers Among South Indian Psychiatric Patients: A Pharmacogenetic Perspective Toward Precision Psychopharmacology. Annals Neurosci. https:\/\/doi.org\/10.1177\/09727531251379157 (2025).","journal-title":"Annals Neurosci."},{"issue":"2","key":"44969_CR20","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ana.26955","volume":"96","author":"C Chen","year":"2024","unstructured":"Chen, C., Reeves, M. J., He, K., Morgenstern, L. B. & Lisabeth, L. D. Sex differences in trends in stroke recurrence and postrecurrence mortality 2000\u20132020: Population-based Brain Attack Surveillance in Corpus Christi project. Ann. Neurol. 96(2), 332\u2013342. https:\/\/doi.org\/10.1002\/ana.26955 (2024).","journal-title":"Ann. Neurol."},{"key":"44969_CR21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2147\/NDT.S442507","volume":"20","author":"SN Mbalinda","year":"2024","unstructured":"Mbalinda, S. N. et al. Stroke recurrence rate and risk factors among stroke survivors in sub-Saharan Africa: A systematic review. Neuropsychiatr. Dis. Treat 20, 783\u2013791. https:\/\/doi.org\/10.2147\/NDT.S442507 (2024).","journal-title":"Neuropsychiatr. Dis. Treat"},{"issue":"3","key":"44969_CR22","doi-asserted-by":"publisher","first-page":"e13949","DOI":"10.1016\/j.heliyon.2023.e13949","volume":"9","author":"A Chiangkhong","year":"2023","unstructured":"Chiangkhong, A., Suwanwong, C. & Wongrostrai, Y. Lifestyle, clinical, and occupational risk factors of recurrent stroke among the working-age group: A systematic review and meta-analysis. Heliyon 9(3), e13949. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13949 (2023).","journal-title":"Heliyon"},{"issue":"8","key":"44969_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011696","volume":"8","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. Impact of smoking status on stroke recurrence. J. Am. Heart Assoc. 8(8), e011696. https:\/\/doi.org\/10.1161\/JAHA.118.011696 (2019).","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"44969_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2725","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Association between diabetes duration and 1-year prognosis of stroke: A national registry study. Brain Behav. 12(9), e2725. https:\/\/doi.org\/10.1002\/brb3.2725 (2022).","journal-title":"Brain Behav."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44969-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:35:45Z","timestamp":1779147345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44969-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44969"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44969-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We declare that this manuscript is not a duplicate or overlapping publication. The ABCB1 and P2Y12 studies were conducted independently with different cohorts and are submitted as separate manuscripts. Neither manuscript is dependent on the acceptance of the other.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Dual publication"}}],"article-number":"15432"}}